Programme Overview

The conference committee is hard at work finalizing this year’s programme. Be prepared to take on the challenges with the latest knowledge and vital updates in European regulatory. RAPS Euro Convergence provides the essential knowledge in the areas of medical device, IVD, and pharmaceutical industries to ensure that the most important information is provided to you.

Registration

RAPS Euro Convergence will bring delegates 40 plus education sessions.*

*as of January 2021

 

IVDR
22
Medical Device sessions
IVDR
11
IVD
sessions
IVDR
12
Pharma
sessions

 

 

 

 

 

 

Euro Convergence 2021 Programme

The full programme is now available with session titles and dates, descriptions, speakers, an interactive planner and more! 

 View Programme

 

Euro Convergence 2021 Conference Committee

 

A special thank you to this year’s conference committee for cultivating an impressive programme line-up for this year’s event!

 
Gert Bos
Gert Bos (Co-Chair)

Executive Director & Partner, QserveGroup

Philippe Auclair
Philippe Auclair

Senior Director. Regulatory Strategy and Advocacy, Abbott Laboratories

Mats Ericson
Mats Ericson

Regulatory Policy Director. Amgen

Irena Medarevic-Milobratovic
Irena Medarevic-Milobratovic

Senior Regulatory Affairs Manager, Arriello

Richard Vincins
Richard Vincins

VP Regulatory Affairs, Oriel Stat A Matrix

Sabina Hoekstra-van den Bosch
Sabina Hoekstra-van den Bosch (Co-Chair)

Regulatory Strategy Principal, TÜV SÜD

Rosie Dawes
Rosie Dawes

EU+ Regulatory Lead, LEO Pharma

Leo Louis
Leo Louis

Sr. Regulatory Affairs Manager, Philips

Siegfried Schmitt
Siegfried Schmitt

Vice President Technical PAREXEL

Anja Wiersma
Anja Wiersma

CEO and senior consultant mi-CE consultancy

Eric Klasen
Eric Klasen (Co-Chair)

Life Sciences expert in Regulatory & QA solutions, Waypoint LS

Giovanni Di Rienzo
Giovanni Di Rienzo

Senior Consultant, Qserve

Alex Laan
Alex Laan

Principal Medical Research Manager, NAMSA

Colette Shortt
Colette Shortt

Regulatory Director, Food Observatory

Kim Young
Kim Young

Director, Global Regulatory Intelligence, Instem

Sabine Haubenreisser
Sabine Haubenreisser (Advisor)

Principal Scientific Administrator, European Medicines Agency